Cholecystokinin receptor antagonist, loxiglumide (CR1505), inhibits invasiveness of a human pancreatic cancer cell line

被引：0
|
作者：
Hirata, M [1 ]
Itoh, M [1 ]
Fujii, K [1 ]
Tsuchida, A [1 ]
Hanada, K [1 ]
Ishimaru, S [1 ]
Iwao, T [1 ]
Eguchi, N [1 ]
Kajiyama, G [1 ]
机构：
[1] HIROSHIMA UNIV, SCH MED, DEPT INTERNAL MED 1, HIROSHIMA, JAPAN
来源：
GASTROENTEROLOGY | 1996年 / 110卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A398 / A398
页数：1
相关论文
共 50 条
  • [1] Cholecystokinin receptor antagonist, loxiglumide, inhibits invasiveness of human pancreatic cancer cell lines
    Hirata, M
    Itoh, M
    Tsuchida, A
    Ooishi, H
    Hanada, K
    Kajiyama, G
    FEBS LETTERS, 1996, 383 (03) : 241 - 244
  • [2] LOXIGLUMIDE (CR1505), A CHOLECYSTOKININ ANTAGONIST, SPECIFICALLY INHIBITS THE GROWTH OF HUMAN PANCREATIC-CANCER LINES XENOGRAFTED INTO NUDE-MICE
    NIO, Y
    TSUBONO, M
    MORIMOTO, H
    KAWABATA, K
    MASAI, Y
    HAYASHI, H
    MANABE, T
    IMAMURA, M
    FUKUMOTO, M
    CANCER, 1993, 72 (12) : 3599 - 3606
  • [3] Effect of cholecystokinin1 receptor antagonist loxiglumide (CR1505) on basal pancreatic exocrine secretion in conscious rats
    Ishizaki, K
    Kinbara, S
    Kawamura, M
    Kimura, K
    Shiratori, K
    Takeuchi, T
    PANCREAS, 2003, 26 (01) : 87 - 91
  • [4] EFFECT OF CHOLESTYRAMINE AND CHOLECYSTOKININ RECEPTOR ANTAGONIST CR1505 (LOXIGLUMIDE) ON LOWER ESOPHAGEAL SPHINCTER PRESSURE IN MAN
    MASCLEE, AAM
    ROVATI, JLC
    LAMERS, CBHW
    DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (10) : 1889 - 1892
  • [5] INHIBITION OF STIMULATED PANCREATIC-SECRETION BY THE CHOLECYSTOKININ RECEPTOR ANTAGONIST CR1505 IN MAN
    ADLER, G
    REINSHAGEN, M
    KOOP, I
    ROVATI, L
    ARNOLD, R
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1988, 26 (09): : 442 - 442
  • [6] INHIBITORY EFFECTS OF A CHOLECYSTOKININ ANTAGONIST, LOXIGLUMIDE (CR-1505), ON THE GROWTH OF FRESHLY SEPARATED AND XENOGRAFTED HUMAN PANCREATIC-CANCER
    MORIMOTO, H
    NIO, Y
    TSUBONO, M
    TSENG, CC
    KAWABATA, K
    MASAI, Y
    HAYASHI, H
    BABA, N
    MANABE, T
    HOSOKAWA, Y
    TOBE, T
    JOURNAL OF SURGICAL ONCOLOGY, 1993, 53 (01) : 47 - 53
  • [7] LACK OF EFFECT OF CHOLECYSTOKININ RECEPTOR ANTAGONIST (CR1505) ON RECOVERY OF EXPERIMENTAL PANCREATITIS AFTER PANCREATIC DUCT OCCLUSION IN RATS
    TOMITA, H
    MIYASAKA, K
    JIMI, A
    MISHIMA, Y
    FUNAKOSHI, A
    PANCREAS, 1994, 9 (05) : 638 - 645
  • [8] Dexamethasone inhibits invasiveness of a human pancreatic cancer cell line
    Hirata, M
    Itoh, M
    Tsuchida, A
    Ooishi, H
    Hanada, K
    Kajiyama, G
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1996, 8 (02) : 327 - 330
  • [9] Human thrombin receptor increases invasiveness of a human pancreatic cancer cell line
    Chinswangwatanakul, V
    Kakker, AK
    Williamson, RCN
    BRITISH JOURNAL OF SURGERY, 1998, 85 (03) : 418 - 418
  • [10] Effects of the cholecystokinin A receptor antagonist loxiglumide on the proliferation and cell cycle time of pancreatic acinar cells in rats
    Kanemitsu, Daisuke
    Sakagami, Junichi
    Motoyoshi, Tomoko
    Nakajima, Tomoki
    Kataoka, Keisho
    PANCREAS, 2006, 32 (02) : 190 - 196
12345